[ TRANSACTION RECORD ]

Novo Holdings A/S Investment in Metabolic Drug Hub — 2026

VERIFIED VECTOR ID: 002444 · tx-359
M SOURCE NODE — FUNDER
Novo Holdings A/S
Healthcare Denmark
$1,400,000,000
EQUITY
15/04/2026
Q DESTINATION NODE — RECIPIENT
Metabolic Drug Hub
SPV Denmark
Amount (USD)
$1.4B
Flow Type
EQUITY
Transaction Date
15/04/2026
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Novo Holdings A/S
AUM 125000
HQ Location Denmark
Sector Healthcare
Recipient Profile [ Q ]
Entity Metabolic Drug Hub
Entity Type SPV
Jurisdiction Denmark
Intelligence Note

Novo Holdings A/S finalized a 1.4 billion dollar equity investment to expand the Metabolic Drug Hub in Denmark to increase the global production of life-saving therapies. This transaction supports the installation of advanced bioreactors and automated packaging lines for obesity treatments. The deal is a strategic move to secure the supply chain for world-class health therapies.

Σ
Primary Forensic Source https://www.novoholdings.dk/news/novo-holdings-to-expand-metabolic-drug-hub/
✓ SOURCE LINKED